The efficacy and safety of sorafenib in older adults with advanced hepatocellular carcinoma: An analysis of a majority Hispanic cohort

J Geriatr Oncol. 2020 Sep;11(7):1157-1160. doi: 10.1016/j.jgo.2020.03.018. Epub 2020 Apr 6.
No abstract available

Keywords: Elderly; Geriatric; Hepatocellular carcinoma; Older adult; Sorafenib.

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Aged
  • Antineoplastic Agents* / adverse effects
  • Carcinoma, Hepatocellular* / drug therapy
  • Hispanic or Latino
  • Humans
  • Liver Neoplasms* / drug therapy
  • Niacinamide / adverse effects
  • Phenylurea Compounds / adverse effects
  • Sorafenib / adverse effects
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Phenylurea Compounds
  • Niacinamide
  • Sorafenib